At today's #rFSGSConference, we're connecting patients, families, doctors, researchers, funders, & political leaders to raise awareness of #rFSGS.
The engaging stories told by patients & caregivers have inspired hope for many attendees. 💙💚
We look forward to seeing you tomorrow for the Recurrent Focal Segmental Glomerulosclerosis (#rFSGS) Conference!
🔹7:30 a.m.–5:30 p.m.
🔹Hyatt Regency Washington on Capitol Hill
🔹Washington, DC
View our program to see what's in store: scgcorp.com/rFSGS2024/Agenda#rFSGSConference
At the upcoming #rFSGSConference, you can meet 150 attendees including patients, researchers, members of congress, senators, and more! 🤝
If you want to participate, check out more info on the first ever conference all about #rFSGS! scgcorp.com/rFSGS2024/Defaul…#RareDisease
You're in luck! It's not too late to register for the Recurrent Focal Segmental Glomerulosclerosis (rFSGS) Conference. Visit our website and submit your registration today to join us on Dec. 9: scgcorp.com/rFSGS2024/Regist…#rFSGS#rFSGSConference
🚨 We are officially two weeks out from the #rFSGSConference! 🚨
Reserve your spot so you can join us in Washington, DC to discuss #rFSGS research, funding, and treatments. Register today: scgcorp.com/rFSGS2024/Regist…
The Recurrent Focal Segmental Glomerulosclerosis (rFSGS) Conference is approaching! If you want to join patients with #rFSGS or meet with rFSGS specialists, register & we will see you on Dec. 9, 2024, in Washington, DC! scgcorp.com/rFSGS2024/Regist…#rFSGSConference#RareDisease
📣 Attention all patients with recurrent focal segmental glomerulosclerosis (#rFSGS)!
Secure your spot soon! Join us and other patients on Dec. 9, 2024, at our #rFSGSConference. Let’s work together to raise awareness and increase funding. scgcorp.com/rFSGS2024/Regist…
ALT Connect with patients, families, and researchers at the Recurrent Segmental Glomerulosclerosis (rFSGS) Conference! Register today! www.scgcorp.com/rfsgs2024/Registration
Registration is filling up for the first-ever Recurrent Focal Segmental Glomerulosclerosis Conference and you don't want to miss it! Register today to join us on Monday, Dec. 9, 2024, in Washington, DC. scgcorp.com/rFSGS2024/Regist…#rFSGS#rFSGSConference
➡️Do you have Recurrent Focal Segmental Glomerulosclerosis (rFSGS)?
➡️Do have questions about #rFSGS that specialists could help with?
Join the #rFSGSConference on Dec. 9 to talk with leading experts in the field & have your questions answered! Register: scgcorp.com/rFSGS2024/Regist…
ALT Join us at the Recurrent Focal Segmental Glomerulosclerosis (rFSGS) Conference! Who: rFSGS patients, family members, specialist. Where: Washington, DC. When: Monday, December 9, 2024. #rFSGSConference. www.scgcorp.com/rfsgs2024/
Do you have Recurrent Focal Segmental Glomerulosclerosis (rFSGS) and want to meet other patients like you? 👋
We’re connecting #rFSGS patients from across the globe at the first ever #rFSGSConference on Dec. 9! Register today to secure your spot: scgcorp.com/rFSGS2024/Regist…
Do you, a family member, or someone you know have recurrent FSGS (rFSGS)? The @rFSGSInitiative is hosting a conference on #rFSGS with leading doctors, patients, and families. Please view the website and register by Nov. 9: buff.ly/3TVy2qR#rFSGSConference
.@nephcure CEO Josh Tarnoff is our final #rFSGSConference moderator! He spent 34 years in the pharmaceutical & biotechnology community, moving new therapies closer to reality. He engages with rare kidney disease stakeholders to help advance cures for rare #KidneyDiseases. #rFSGS
ALT Josh Tarnoff, CEO. Moderator at the #rFSGS. www.scgcorp.com/rFSGS2024/
Let's welcome #rFSGSConference moderator Astrid Weins, M.D., Ph.D.! 👋
Dr. Weins is an Assistant Professor of Pathology at @harvardmed & the Chief of Renal Pathology at @MassGenBrigham. Her research includes recurrent focal & segmental glomerulosclerosis (#rFSGS).
ALT Astrid Weins M.D., Ph.D. Moderator at the #rFSGS. www.scgcorp.com/rFSGS2024/
Join Laura Mariani, M.D., at the #rFSGSConference! Dr. Mariani is a nephrologist & clinical researcher at @UMich. She is involved in several clinical & translational NIH-funded research studies in kidney diseases including the Nephrotic Syndrome Study Network (NEPTUNE). #rFSGS